Elanco Animal Health (NYSE: ELAN - Get Free Report) and Amarin (NASDAQ: AMRN - Get Free Report) are

Corient Private Wealth LP lifted its position in shares of Elanco Animal Health Incorporated (NYSE:

INDIANAPOLIS, Sept. 17, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will att

Elanco Animal Health Incorporated (ELAN) Presents at Morgan Stanley 24th Annual Global Healthcare Co

Innovation that protects against these pests is driving stronger Elanco base business and overall sh

Squarepoint Ops LLC acquired a new position in shares of Elanco Animal Health Incorporated (NYSE: EL

INDIANAPOLIS, Sept. 11, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will ann

INDIANAPOLIS, Sept. 10, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will att

The purchase was valued at $936,000. This investment increased the insider's direct equity position

Canada Pension Plan Investment Board purchased a new position in Elanco Animal Health Incorporated (

Corient Private Wealth LP purchased a new stake in shares of Elanco Animal Health Incorporated (NYSE

Corient Private Wealth LP raised its stake in Elanco Animal Health Incorporated (NYSE: ELAN) by 127.

Algert Global LLC trimmed its holdings in Elanco Animal Health Incorporated (NYSE: ELAN) by 19.0% du

The completed 25,000-square-foot Elwood site expansion bolsters Elanco's monoclonal antibody (mA

The completed 25,000-square-foot Elwood site expansion bolsters Elanco's monoclonal antibody (mAb) p

I recommend a buy rating for Elanco Animal Health, driven by a strong new product cycle and robust c

The director upped their stake by 10,000 shares. This purchase increased the insider's direct equity

On CNBC's “Halftime Report Final Trades,” Jason Snipe, founder and chief investment officer of Odyss

Bryn Talkington picked Horizon Kinetics, Stephanie Link chose Elanco Animal Health, and Jason Snipe

Elanco Animal Health is transitioning from a leveraged consolidator to an innovative competitor, wit

Elanco Animal Health NYSE: ELAN reported second-quarter 2026 revenue of $1.368 billion, up 10% on a

Elanco's CLiK™ Extra (dicyclanil topical suspension) Wound Spray Receives FDA Emergency Use Author

UBS analyst Andrea Alfonso maintains Elanco Animal Health (NYSE:ELAN) with a Buy and raises the p

Keybanc analyst Steve Dechert maintains Elanco Animal Health (NYSE:ELAN) with a Overweight and r

Elanco beat second-quarter estimates, raised 2026 guidance and cited strong Pet Health demand, Zenre

US stocks rise, Wynn Resorts beat earnings expectations, share price jumps 10.9%. Other companies re

Elanco Animal Health (NYSE:ELAN) is looking for Q3 Adj EPS of $0.19-$0.22 vs $0.20 analyst estimate.

Elanco Animal Health (NYSE:ELAN) raises FY2026 Adj EPS guidance from $1.03-$1.09 to $1.10-$1.16 vs $

Morgan Stanley analyst Erin Wright maintains Elanco Animal Health (NYSE:ELAN) with a Equal-Weight

Newly Published Data Found Credelio Quattro:Faster2 Tick1 Speed of Kill: Credelio Quattro is the onl

Top analysts changed outlook on top names: Intuit downgraded, Alkermes price target raised, Carmax t

TD Cowen analyst Steve Scala maintains Elanco Animal Health (NYSE:ELAN) with a Buy and raises the

Elanco Animal Health Incorporated (NYSE:ELAN) today announced plans to establish Elanco Ventures, a

TruCan Ultra Lyme-L4 is the first and only 1/2 mL combination vaccine protecting against both Lyme d

Company offers portfolio of treatment options and expert guidance following first confirmed case in 

Cramer says Zoetis has issues. Prefers this stock in animal health industry. Energy Transfer is in a

Elanco Animal Health Incorporated (NYSE:ELAN) today announced the phased launch of Befrena™ (tirnove

Citigroup analyst Daniel Grosslight maintains Elanco Animal Health (NYSE:ELAN) with a Buy and rai

JP Morgan analyst Chris Schott maintains Elanco Animal Health (NYSE:ELAN) with a Overweight and r

Elanco Animal Health rallies after emergency use approvals and Q1 earnings beat, with higher guidanc

Elanco Animal Health (NYSE:ELAN) is looking for Q2 Adj EPS of $0.25-$0.28 vs $0.29 analyst estimate.

Elanco Animal Health (NYSE:ELAN) raises FY2026 Adj EPS guidance from $1.00-$1.06 to $1.03-$1.09 vs $

Elanco Animal Health (NYSE:ELAN) reported quarterly earnings of $0.40 per share which beat the analy

Action Prepares Veterinarians and Livestock Producers with Prevention and Treatment Options Prior to

Citigroup analyst Daniel Grosslight initiates coverage on Elanco Animal Health (NYSE:ELAN) with a

U.S. stocks rebound as investors look past rising oil prices and focus on the Fed's rate decisio

Morgan Stanley analyst Erin Wright maintains Elanco Animal Health (NYSE:ELAN) with a Equal-Weight

Keybanc analyst Steve Dechert maintains Elanco Animal Health (NYSE:ELAN) with a Overweight and r